Abstract
In severe heart disease, parenteral administration of loop diuretic is often needed. We present clinical outcomes from episodes of care using subcutaneous continuous subcutaneous infusion of furosemide (CSCI-furosemide).
| Original language | English |
|---|---|
| Pages (from-to) | 112-116 |
| Journal | BMJ Supportive and Palliative Care |
| Volume | 13 |
| Issue number | 1 |
| Early online date | 15 Jan 2021 |
| DOIs | |
| Publication status | Published - 15 Jan 2021 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Subcutaneous furosemide in advanced heart failure: service improvement project'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver